A pharmaceutical company that whistleblowers alleged paid doctors to prescribe its main drug and urged salespeople to push it as a way to control unruly dementia patients will pay more than $100 million to settle government fraud allegations.
원문출처 : https://www.cnn.com/2019/09/26/health/nuedexta-avanir-doj-settlement-invs/index.html
원문출처 : https://www.cnn.com/2019/09/26/health/nuedexta-avanir-doj-settlement-invs/index.html